North America Pain Management Drugs Market Size & Outlook
North America pain management drugs market highlights
- The North America pain management drugs market generated a revenue of USD 33,689.4 million in 2024.
- The market is expected to grow at a CAGR of 4% from 2025 to 2033.
- In terms of segment, nsaids was the largest revenue generating drug class in 2024.
- NSAIDs is the most lucrative drug class segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2024 | USD 33,689.4 million |
| Market revenue in 2033 | USD 47,794.0 million |
| Growth rate | 4% (CAGR from 2025 to 2033) |
| Largest segment | Nsaids |
| Fastest growing segment | NSAIDs |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NSAIDs |
Other key industry trends
- In terms of revenue, North America region accounted for 42.7% of the global pain management drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 25,769.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pain Management Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Depomed, Inc. | View profile | - | - | - |
| Mallinckrodt Pharmaceuticals | View profile | - | - | - |
| GlaxoSmithKline PLC | View profile | - | - | - |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
North America pain management drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pain management drugs market will help companies and investors design strategic landscapes.
Nsaids was the largest segment with a revenue share of 103.97% in 2024. Horizon Databook has segmented the North America pain management drugs market based on nsaids covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America pain management drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America pain management drugs market databook
-
Our clientele includes a mix of pain management drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pain management drugs market , including forecasts for subscribers. This continent databook contains high-level insights into North America pain management drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
